List of Contents

Image Guided Surgery Devices Market Size, Share, and Trends 2024 to 2034

Image Guided Surgery Devices Market (By Product: Image Guided Surgery Devices, Image Guided Surgery Software; By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research & Academic Institutions; By Application: Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Oncology Surgery, Gastroenterology, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

  • Last Updated : August 2023
  • Report Code : 2280
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Image Guided Surgery Devices Market 

5.1. COVID-19 Landscape: Image Guided Surgery Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Image Guided Surgery Devices Market, By Product

8.1. Image Guided Surgery Devices Market, by Product, 2023-2032

8.1.1 Image Guided Surgery Devices

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Image Guided Surgery Software

8.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Image Guided Surgery Devices Market, By End User

9.1. Image Guided Surgery Devices Market, by End User, 2023-2032

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Ambulatory Surgical Centers

9.1.2.1. Market Revenue and Forecast (2021-2032)

9.1.3. Specialty Clinics

9.1.3.1. Market Revenue and Forecast (2021-2032)

9.1.4. Research & Academic Institutions

9.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Image Guided Surgery Devices Market, By Application 

10.1. Image Guided Surgery Devices Market, by Application, 2023-2032

10.1.1. Cardiac Surgery

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Neurosurgery

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Orthopedic Surgery

10.1.3.1. Market Revenue and Forecast (2021-2032)

10.1.4. Urology

10.1.4.1. Market Revenue and Forecast (2021-2032)

10.1.5. Oncology Surgery

10.1.5.1. Market Revenue and Forecast (2021-2032)

10.1.6. Gastroenterology

10.1.6.1. Market Revenue and Forecast (2021-2032)

10.1.7. Others

10.1.7.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Image Guided Surgery Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2021-2032)

11.1.2. Market Revenue and Forecast, by End User (2021-2032)

11.1.3. Market Revenue and Forecast, by Application (2021-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.1.4.2. Market Revenue and Forecast, by End User (2021-2032)

11.1.4.3. Market Revenue and Forecast, by Application (2021-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.1.5.2. Market Revenue and Forecast, by End User (2021-2032)

11.1.5.3. Market Revenue and Forecast, by Application (2021-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.2. Market Revenue and Forecast, by End User (2021-2032)

11.2.3. Market Revenue and Forecast, by Application (2021-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.4.2. Market Revenue and Forecast, by End User (2021-2032)

11.2.4.3. Market Revenue and Forecast, by Application (2021-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.5.2. Market Revenue and Forecast, by End User (2021-2032)

11.2.5.3. Market Revenue and Forecast, by Application (2021-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.6.2. Market Revenue and Forecast, by End User (2021-2032)

11.2.6.3. Market Revenue and Forecast, by Application (2021-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2021-2032)

11.2.7.2. Market Revenue and Forecast, by End User (2021-2032)

11.2.7.3. Market Revenue and Forecast, by Application (2021-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.2. Market Revenue and Forecast, by End User (2021-2032)

11.3.3. Market Revenue and Forecast, by Application (2021-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.4.2. Market Revenue and Forecast, by End User (2021-2032)

11.3.4.3. Market Revenue and Forecast, by Application (2021-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.5.2. Market Revenue and Forecast, by End User (2021-2032)

11.3.5.3. Market Revenue and Forecast, by Application (2021-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.6.2. Market Revenue and Forecast, by End User (2021-2032)

11.3.6.3. Market Revenue and Forecast, by Application (2021-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2021-2032)

11.3.7.2. Market Revenue and Forecast, by End User (2021-2032)

11.3.7.3. Market Revenue and Forecast, by Application (2021-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.2. Market Revenue and Forecast, by End User (2021-2032)

11.4.3. Market Revenue and Forecast, by Application (2021-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.4.2. Market Revenue and Forecast, by End User (2021-2032)

11.4.4.3. Market Revenue and Forecast, by Application (2021-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.5.2. Market Revenue and Forecast, by End User (2021-2032)

11.4.5.3. Market Revenue and Forecast, by Application (2021-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.6.2. Market Revenue and Forecast, by End User (2021-2032)

11.4.6.3. Market Revenue and Forecast, by Application (2021-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2021-2032)

11.4.7.2. Market Revenue and Forecast, by End User (2021-2032)

11.4.7.3. Market Revenue and Forecast, by Application (2021-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.5.2. Market Revenue and Forecast, by End User (2021-2032)

11.5.3. Market Revenue and Forecast, by Application (2021-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2021-2032)

11.5.4.2. Market Revenue and Forecast, by End User (2021-2032)

11.5.4.3. Market Revenue and Forecast, by Application (2021-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2021-2032)

11.5.5.2. Market Revenue and Forecast, by End User (2021-2032)

11.5.5.3. Market Revenue and Forecast, by Application (2021-2032)

Chapter 12. Company Profiles

12.1. GE Healthcare

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Medtronic Plc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Olympus Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Siemens Healthineer

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Koninklijke Philips N.V.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Analogic Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Brainlab AG

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Karl Storz Gmbh & Co. KG

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Stryker Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Varian Medical Systems Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client